Since pharmacological inhibition of POLQ attenuates the stemness of GC cells and sensitizes gastric cancer to ferroptosis, we further investigated the therapeutic potential of combined treatment with POLQ inhibitors and ferroptosis inducers in treating gastric tumors in vivo. The gene discussed is POLQ; the disease is gastric cancer.